Impact of Aorto-Iliac Occlusive Disease Treatment on Blood Pressure
Eligible age
18+ yrs
Accepts
All genders
Locations
0 states
Healthy volunteers
No
See if you qualify for this study
Answer a few quick questions about your location and health. Takes about a minute.
About this study
Hypertension is a major risk factor for a variety of cardiovascular diseases. When hypertension results from increased vascular resistance due to a narrowing of the descending aorta, it can be effectively treated with stenting. More recently, evidence suggest that stenting in more distal parts of the arterial vascular bed is also associated with a reduction in blood pressure. The investigators hypothesize that stenting of occlusions more distal of the descending aorta decreases the central blood pressure and afterload as reflected by NT-proBNP (N-terminal pro-Brain Natriuretic Peptide), a biomarker of intracardiac pressures and predictor of heart failure events. The goal of this pilot study is to prospectively investigate changes in blood pressure after stent placement in the aorto-iliac region.
Sponsor: Rijnstate Hospital
You may qualify if…
- ✓ Age ≥18 years
- ✓ Singed informed consent
- ✓ Chronic occlusion in the infrarenal aorta and/or one or both common iliac arteries
- ✓ Total lesion length of ≥30mm
- ✓ Clinical indication for treatment of the pathology (Chronic limb threatening ischemia or disabling intermittent claudication not responding to supervised exercise training)
You may not qualify if…
- ✕ Patient is unable to understand the study requirements and/ or is unwilling to adhere to the follow-up
- ✕ Juxtarenal pathology (\<2cm below the lowest renal artery)
- ✕ Acute occlusion of the target area (Acute Leriche Syndrome)
- ✕ Embolic disease
Source: ClinicalTrials.gov · NCT07070583 · last updated 2026-04-03